TrialPloS one2009
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.
Michele D Spring et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
133 papers cite itlatest 60 shown
this paperpooled ittrialcites it